EANS-Adhoc: Publication pursuant to Sections 4 and 5 of the Publication Ordinance 2002 INTERCELL AG, ISIN: AT0000612601

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

20.07.2010

Since 2002, the shareholders meeting of Intercell AG has issued stock options on
a regular basis to members of the management board, the supervisory board and
employees. According to section 98 para 3 and section 159 para 2 lit 3 of the
Austrian stock corporation act, the management board has published a report on
the option grant. In connection with the exercise of stock options during the
last exercise window in June/July 2010 the Company intends to use own shares
held as treasury stock, in addition to new shares issued from conditional
capital.´

Therefore, the Management Board of Intercell AG has resolved on July 16, 2010 in
accordance with the Supervisory Board, to transfer own shares held as treasury
stock, which have been acquired according to the resolutions of the Shareholders
Meetings held on May 24, 2002, on July 14, 2003 and on June 1, 2004 to members
of the management board, the supervisory board and employees of Intercell AG in
connection with the exercise of stock options.

Based on the above mentioned resolutions of the Shareholders Meetings, in which
the authorizations to re-purchase own shares were approved according to Section
65 para 1 lit 4 of the Austrian stock corporations act, Intercell AG herewith
informs about the upcoming transfer of up to 150,000 own shares of common stock
with no par value, corresponding to up to 0.31 percent of the share capital of
Intercell AG, to members of the management board, the supervisory board and
employees of Intercell AG between July 23, 2010 and August 31, 2010. The
transfer shall be conducted over-the-counter at a sales price equivalent to the
exercise price of the stock options ranging from EUR 3.99 to EUR 11.43 per
share. The transfer shall not affect the admission of shares of Intercell AG at
the Vienna Stock exchange.

Until now, the following numbers of stock options have been granted to members
of the Supervisory Board, members of the Management Board, executive employees
and other employees (excluding options that have been cancelled):

Beneficiaries                           Number of options

Members of the Supervisory Board
  Michel Gréco                                     51,250
  Ernst Afting                                     51,250
  David Ebsworth                                   45,000
  James R. Sulat                                   47,500
  Hans Wigzell                                     45,000
  Mustapha Leavenworth Bakali                      50,000

Members of the Management Board 
  Gerd Zettlmeissl                                475,000
  Thomas Lingelbach                               350,000
  Reinhard Kandera                                187,000

Executive employees                             1,002,400
Other employees                                   246,850
Employees of subsidiaries                         818,687

Total                                           3,369,937

According to Section 7 para 2 in connection with Section 5 para 4 of the
Publication Ordenance 2002 Intercell AG informs, that the disclosure obligation
according to Section 7 of the Publication Ordenance 2002 (completion of the
transfer) shall be effected via the internet. The information according to
Section 7 of the Publication Ordenance 2002 shall be posted on the webpage of
Intercell AG under www.intercell.com.

INTERCELL AG

Further inquiry note:
Intercell AG
Gerald Strohmaier
Global Head Corporate Finance & Investor Relations
Tel. +43 1 20620-1229
[email protected]
end of announcement euro adhoc
--------------------------------------------------------------------------------

issuer:   Intercell AG
          Campus Vienna Biocenter  3
          A-1030 Wien 
phone:    +43 1 20620-0
FAX:      +43 1 20620-800
mail:     [email protected] 
WWW:      www.intercell.com
sector:   Biotechnology

ISIN: AT0000612601
indexes: ATX Prime, ATX
stockmarkets: official market: Wien
language: English

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS - WWW.OTS.AT | OTB

print